PAFP 2013 Regional Lecture Series
Session 1 - Northeast
Presenter: Linda Thomas-Hemak, MD
The Wright Center for Primary Care
Broadcast live through the PAFP Community.
October 2nd, 2013 12pm - 1pm
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
1. Shaping the Future of Healthcare | www.thewrightcenter.org
Point of Care Testing for
Enhancing Patient Centered Planned Care Delivery
Linda Thomas-Hemak, MD
The Wright Center for Primary Care
PAFP Community Regional Lecture Series
October 2, 2013
2. Shaping the Future of Healthcare | www.thewrightcenter.org
Learning Goals and Objectives
• Review Availability, Advantages , Disadvantages and
Challenges of POCT.
• Describe how POCT for HbA1c and Lipids can
contribute to improved team based planned care
delivery in the patient-centered medical home.
• Demonstrate a plan for effective, affordable
implementation of Point of Care HbA1c and Lipid
testing, including factors such as staff buy-in and
effective use of Health Information Technology.
2
3. Shaping the Future of Healthcare | www.thewrightcenter.org
POCT Relevance
• Care emphasis is shifting toward prevention and early
detection of disease, as well as effective, facilitated
self-management of multiple chronic conditions with
development of low-cost technologies for POCT.
• With miniaturized devices and wireless
communication, doctors’ care for patients will change
dramatically, and the role patients take in their own
health care will increase.
3
4. Shaping the Future of Healthcare | www.thewrightcenter.org
Definition and Aim of Point Of Care Testing
• Point-Of-Care Testing is defined as testing at
the patient encounter in whatever venue
patient care is delivered.
• The aim of POCT is to accelerate diagnostic
and therapeutic processes.
4
5. Shaping the Future of Healthcare | www.thewrightcenter.org
POCT Empowers Providers and Patients
• Promotes evidence based planned care at every visit.
• Potential to address compliance, significantly impact
health care delivery, enhance outcomes and reduce
health disparities.
• Enhances the shift to predictive, personalized and
preemptive medicine with the development of
portable diagnostic and monitoring devices.
5
6. Shaping the Future of Healthcare | www.thewrightcenter.org
Implementing POCT
• Obtain leadership buy in to coordinate POCT
program in everyday workflow.
• Understand POCT methodology and economics.
• Financial modeling (Can we effort it?).
• Define POCT role specific, team based work flow.
• Keep it integrated in EMR MU and Lab interfaces.
• Be certain lab orders are accommodated to avoid
duplicated testing and denied service coverage.
• Implement and Evaluate.
6
7. Shaping the Future of Healthcare | www.thewrightcenter.org
POCT “Lean” Benefits
• Rapid turn around time for diagnosis and management
planning
• Patient convenience
• Reasonable cost
• Improved patient planned care provided
• Empowered patient self management
• Improved office workflow through increased testing
efficiency and less call backs
• Reduction of length of stay in ER venues
• Reduced ER and Hospital referrals
7
8. Shaping the Future of Healthcare | www.thewrightcenter.org
Additional POCT Advantages
• Small sample volume
• Portable devices with wide menu of analytes
• Unprocessed specimen
• Ability to provide laboratory testing in a wider variety
of sites or circumstances
• Reduced potential for sample deterioration
8
9. Shaping the Future of Healthcare | www.thewrightcenter.org
POCT Disadvantages
• Implementation is challenging and must be strategic.
• Not all methods are appropriate for diagnosis or
monitoring treatment.
• Kits/devices may not be FDA approved for all uses of a
similar test in central laboratories.
• Different methodology, reliability, and precision
• Variable coverage and affordability
• Staff time and training
• Staff inappropriate use outside of intended use or policy
• Costs of specimen mistakes
9
10. Shaping the Future of Healthcare | www.thewrightcenter.org
Affordability and Value :
Complex POCT Economics
• Staffing, training and visit time
• ↓ Call backs but potentially ↓ # of clinic visits
• More efficient and potentially more aggressive
chronic disease management
• Less inappropriate Rx
• Potentially enhanced patient self management
• Fewer unnecessary ER visits and admissions
• ↓ ER and Hospital LOS
• ↓ blood and blood product use
• Potentially enhanced outcomes and QOL
10
11. Shaping the Future of Healthcare | www.thewrightcenter.org
POCT Improved Outcomes Examples
• Faster diagnosis and treatment decision making: Chest
pain, Drug O/D
• Improved adherence to Rx: Diabetes & Glucometers
• Faster therapeutic optimization : Anticoagulation
• Reduced re-operation rate: Parathyroidectomy (with
rapid point-of-care PTH assays)
• Improved patient satisfaction:
↓travel, ↓cost,↑ownership of diagnosis
• No validated primary care health outcomes yet
11
12. Shaping the Future of Healthcare | www.thewrightcenter.org
POCT Economics: Cost
Cost must look at the whole process of patient care,
rather than just the cost of an individual POCT method
vs. laboratory test methods.
– Management, billing and HIT plans
– training testing personnel
– labor to process/analyze specimens
– maintaining equipment, annual reagent/controls
– depreciation costs
– state licensing for volume and test complexity
– proficiency programs for testing performed.
12
13. Shaping the Future of Healthcare | www.thewrightcenter.org
POCT Cost Effectiveness
• Many studies show POCT for various applications is a
useful complement to conventional laboratory testing.
• POCT should not be viewed as a significant profit
generator.
• The true value is lean improvement in care provided,
patient satisfaction with their healthcare and possibly
outcomes.
• Future utilization will depend not only on technical
advances, but also on enhancement in costs and
reimbursement, as well as transformation from a
volume driven to value based payment system.
13
14. Shaping the Future of Healthcare | www.thewrightcenter.org
Available POCT
• Cardiac markers
• Drug/toxicology
• Hemoglobin A1c
• INR
• Heparin
• D-Dimer for VTE
• Magnesium & Lactate
• Lipids
• Transcutaneous bilirubin
• Micro-albumin, Creatinine
• HIV
• RSV, Influenza
• Helicobacter pylori
• Other bacteria
• Urine dip tests including
pregnancy
14
15. Shaping the Future of Healthcare | www.thewrightcenter.org
POCT We Utilize
• Sugar
• Hg A1C
• Lipid Profile
• INR
• Urinalysis and Pregnancy test
• Lead and H&H
• Rapid Strep
• RSV
• Rapid Flu A/B
15
16. Shaping the Future of Healthcare | www.thewrightcenter.org
POCT Precision for HbA1c and Lipids
• Comparison studies to reference labs are
standardized and available
• Scatter Plots useful
• Correlation Coefficients > 95%
• Correlation Variables < 2%
16
17. Shaping the Future of Healthcare | www.thewrightcenter.org
HbA1c POCT Volumes All Patients
Total tests performed (11/1/12 – 4/30/13)
• # HbA1c on All Patients (DM, Pre-Diabetics, PCOS,
Suspected diabetics) = 496
• # HbA1c done on All Patients by POCT = 207
• 42 % of all HbA1cs were performed in house for the
entire population
17
18. Shaping the Future of Healthcare | www.thewrightcenter.org
HbA1c POCT Volume of Diabetic Patients
Total tests performed (11/1/12 – 4/30/13)
• # HbA1c on DM Patients Total = 312
• # HbA1c on DM Patients done by POCT = 174
• 56 % of all HbA1cs were performed in house
for the diabetic population
18
19. Shaping the Future of Healthcare | www.thewrightcenter.org
Lipids POCT Volumes All Patients
Total tests performed (11/1/12 – 4/30/13)
• # Lipids on All Patients = 1136
• # Lipids done on All patients by POCT = 80
• Only 7% of all Lipid panels were performed in
house for the entire population
19
20. Shaping the Future of Healthcare | www.thewrightcenter.org
Lipids POCT Volumes Diabetes Patients
Total tests performed (11/1/12 – 4/30/13)
• # Lipids done on DM Patients Total = 225
• # of Lipids done on DM patients by POCT = 44
• 20% of all Lipid Panels were performed in
house for the diabetic population
20
21. Shaping the Future of Healthcare | www.thewrightcenter.org
Patient Volume for HbA1c & Lipid POCT
21
42%
56%
7%
20%
58%
44%
93%
80%
0%
20%
40%
60%
80%
100%
120%
HbA1c
(All Patients)
HbA1c
(Diabetic
Patients)
Lipid Panel
(All Patients)
Lipid Panel
(Diabetic
Patients)
Patients with testing d
OFFSITE
Patients with testing d
POC
22. Shaping the Future of Healthcare | www.thewrightcenter.org
How HIT Can Promote Affordability and Value
• POCT device costs and insurance checklists for
covered services
• POCT affordability reports can track service
counts, charges and receipts
• DM/HM Alerts can reflect coverage eligibility
• Integrating with EMR Lab interfaces can optimize
tracking
• Customized EMR lab orders avoids duplicate tests
• Inventory reconciliation can capture lost charges
22
23. Shaping the Future of Healthcare | www.thewrightcenter.org
POCT
CHECK
LIST OF
WCPC
23
87880-Strep Allowance Cost
Medicare $15.13 $1.87 $13.26 Profit
MA products $6.30 $1.87 $4.43 Profit
Geisinger $12.31 $1.87 $10.44 Profit
Blue Shield $15.29 $1.87 $13.42 Profit
First Priority Life $11.76 $1.87 $9.89 Profit
81025_Pregnancy Test
Medicare $8.70 $1.00 $7.70 Profit
MA products $4.00 $1.00 $3.00 Profit
Geisinger $7.07 $1.00 $6.07 Profit
Blue Shield $7.83 $1.00 $6.83 Profit
First Priority Life $6.47 $1.00 $5.47 Profit
87807-RSV
Medicare $16.49 $11.36 $5.13 Profit
MA Products $12.31 $11.36 $.95 Profit
Geisinger $12.31 $11.36 $.95 Profit
Blue Shield $11.89 $11.36 $.53 Profit
First Priority Life $15.00 $11.36 $3.64 Profit
87804-Rapid Flu A/B
Medicare $16.49 x 2 = $32.98 $12.50 $20.48 Profit
Ma Products $11.35 x 2 = $22.70 $12.50 $10.20 Profit
Geisinger $12.31 x 2 = $24.62 $12.50 $12.12 Profit
Blue Shield $14.84 x 2 = $29.68 $12.50 $17.18 Profit
First Priority Life $11.76 x 2 = $23.52 $12.50 $11.02 Profit
24. Shaping the Future of Healthcare | www.thewrightcenter.org
POCT
CHECK
LIST
24
80061-Lipid Profile ALLOWANCE COST
Medicare $18.42 $10.80 $7.62 Profit
Ma Products $14.00 $10.80 $3.20 Profit
Geisinger $14.98 $10.80 $4.18 Profit
Blue Shield $15.25 $10.80 $4.45 Profit
First Priority Life $21.73 $10.80 $10.93 Profit
83036 - Hg A1C
Medicare $13.34 $8.33 $5.01 Profit
Ma Products 0
Geisinger $10.85 $8.33 $2.52 Profit
Blue Shield $9.63 $8.33 $1.30 Profit
First Priority Life $9.92 $8.33 $1.59 Profit
83655-Lead
Medicare $16.64 $7.32 $9.32 Profit
Ma Products $10.00 $7.32 $2.68 Profit
Geisinger $13.53 $7.32 $6.21 Profit
Blue Shield $11.65 $7.32 $4.33 Profit
First Priority Life $12.37 $7.32 $5.05 Profit
85013 -
Medicare $3.26 $0.58 $2.68 Profit
Ma Products $3.27 $0.58 $2.69 Profit
Geisinger $2.65 $0.58 $2.07 Profit
Blue Shield $2.34 $0.58 $1.76 Profit
First Priority Life $2.42 $0.58 $1.84 Profit
85018 -
Medicare $3.26 $0.57 $2.69 Profit
Ma Products $3.27 $0.57 $2.70 Profit
Geisinger $2.65 $0.57 $2.08 Profit
Blue Shield $2.34 $0.57 $1.77 Profit
First Priority Life $2.42 $0.57 $1.85 Profit
85610- Protime Profit Alone 99211 - Level 1 OV Profit w/Level 1
Medicare $5.40 $4.69 $.71 Profit $19.24 $19.95
Ma Products $4.00 $4.69 $20.00 $19.31
Geisinger $4.39 $4.69 $20.08 $19.78
Blue Shield $3.78 $4.69 $30.00 $29.09
First Priority Life $5.62 $4.69 $.93 Profit $26.00 $26.93
With the Coumadin
Clinic we charge a
Level 1 visit along
with the 85610
25. Shaping the Future of Healthcare | www.thewrightcenter.org
Track, Promote and Determine Affordability
25
Allowance Cost Profit
80061-Lipid Profile
Medicare $18.42 $10.80 $7.62 Profit
Ma Products $14.00 $10.80 $3.20 Profit
Geisinger $14.98 $10.80 $4.18 Profit
Blue Shield $15.25 $10.80 $4.45 Profit
First Priority Life $21.73 $10.80 $10.93 Profit
83036 - HbA1c
Medicare $13.34 $8.33 $5.01 Profit
Ma Products 0
Geisinger $10.85 $8.33 $2.52 Profit
Blue Shield $9.63 $8.33 $1.30 Profit
First Priority Life $9.92 $8.33 $1.59 Profit
26. Shaping the Future of Healthcare | www.thewrightcenter.org
6 Month Revenue Generated
26
27. Shaping the Future of Healthcare | www.thewrightcenter.org
Affordability Punch Line
• HbA1c Per Service Collection $7.83 versus cost
of $8.33
– Net Loss of $ 49 over 6 month period
• Lipids Per Service Collection $14.10 versus
cost of $10.80
– Net Profit of $280 over 6 month period
27
28. Shaping the Future of Healthcare | www.thewrightcenter.org
Affordability Punch Line Excluding
Uncovered Services
• HBA1C Per Service Collection $ 9.85 versus
cost of $ 8.33
• Six Month Profit: $259
28
29. Shaping the Future of Healthcare | www.thewrightcenter.org
Have we changed patient outcomes?
• A complex question
• Providers and patients reportedly like it and
believe it enhances planned care provision
and chronic disease management at POC.
• Staff aren’t complaining.
• There was no time based overlay in our
HBA1C or LDL process or outcomes run
charts with POCT implementation.
29
30. Shaping the Future of Healthcare | www.thewrightcenter.org
Conclusion
Selective POCT makes sense, especially for
high volume primary care delivery test metrics
like HbA1c and Lipids.
Test cost: reimbursement of HbA1c and Lipids
are close to neutral.
Affordability and value delivery assessments
are complex.
30
32. Shaping the Future of Healthcare | www.thewrightcenter.org
For HbA1c testing we use
• Afinion AS100
Analyser for HbA1c
• The coefficient of
Variability (CV) is
1.51% to 1.97%
32
33. Shaping the Future of Healthcare | www.thewrightcenter.org
For Lipid testing we use
33
• Cholestech LDX for
lipid
• The Coefficient of
Variability (CV) is 2-3%